Alligator Bioscience, a Swedish research-based biotechnology company focused on antibody therapeutics for cancer, announced on Aug. 20, 2019 that it is entering into a license agreement with Biotheus, a privately held Chinese company based in Zhuhai, Guangdong, China. The agreement gives BiotheuOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.